Table of Content

1 Study Coverage
1.1 Vaccine Adjuvants Product Introduction
1.2 Market by Type
1.2.1 Global Vaccine Adjuvants Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
1.3 Market by Application
1.3.1 Global Vaccine Adjuvants Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
1.4 Global Vaccine Adjuvants Market by Region
1.4.1 Global Vaccine Adjuvants Market by Region: 2019 VS 2024 VS 2030
1.4.2 Global Vaccine Adjuvants Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Vaccine Adjuvants Revenue by Players
2.1.1 Global Vaccine Adjuvants Revenue by Players (2019-2024)
2.1.2 Global Vaccine Adjuvants Revenue Market Share by Players (2019-2024)
2.1.3 Global Top 5 and Top 10 Companies by Vaccine Adjuvants Revenue in 2024
2.2 Global Vaccine Adjuvants Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Vaccine Adjuvants Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 SEPPIC
3.1.1 SEPPIC Information
3.1.2 SEPPIC Overview
3.1.3 SEPPIC Vaccine Adjuvants Revenue and Gross Margin (2019-2024)
3.1.4 SEPPIC Related Developments
3.2 SDA BIO
3.2.1 SDA BIO Information
3.2.2 SDA BIO Overview
3.2.3 SDA BIO Vaccine Adjuvants Revenue and Gross Margin (2019-2024)
3.2.4 SDA BIO Related Developments
3.3 Brenntag Biosector
3.3.1 Brenntag Biosector Information
3.3.2 Brenntag Biosector Overview
3.3.3 Brenntag Biosector Vaccine Adjuvants Revenue and Gross Margin (2019-2024)
3.3.4 Brenntag Biosector Related Developments
3.4 SPI Pharma
3.4.1 SPI Pharma Information
3.4.2 SPI Pharma Overview
3.4.3 SPI Pharma Vaccine Adjuvants Revenue and Gross Margin (2019-2024)
3.4.4 SPI Pharma Related Developments
3.5 MVP Laboratories
3.5.1 MVP Laboratories Information
3.5.2 MVP Laboratories Overview
3.5.3 MVP Laboratories Vaccine Adjuvants Revenue and Gross Margin (2019-2024)
3.5.4 MVP Laboratories Related Developments
3.6 Tj Kaiwei
3.6.1 Tj Kaiwei Information
3.6.2 Tj Kaiwei Overview
3.6.3 Tj Kaiwei Vaccine Adjuvants Revenue and Gross Margin (2019-2024)
3.6.4 Tj Kaiwei Related Developments
3.7 Novavax
3.7.1 Novavax Information
3.7.2 Novavax Overview
3.7.3 Novavax Vaccine Adjuvants Revenue and Gross Margin (2019-2024)
3.7.4 Novavax Related Developments
3.8 Zhuoyue
3.8.1 Zhuoyue Information
3.8.2 Zhuoyue Overview
3.8.3 Zhuoyue Vaccine Adjuvants Revenue and Gross Margin (2019-2024)
3.8.4 Zhuoyue Related Developments
3.9 Aphios
3.9.1 Aphios Information
3.9.2 Aphios Overview
3.9.3 Aphios Vaccine Adjuvants Revenue and Gross Margin (2019-2024)
3.9.4 Aphios Related Developments
3.10 GSK
3.10.1 GSK Information
3.10.2 GSK Overview
3.10.3 GSK Vaccine Adjuvants Revenue and Gross Margin (2019-2024)
3.10.4 GSK Related Developments
3.11 CSL Limited
3.11.1 CSL Limited Information
3.11.2 CSL Limited Overview
3.11.3 CSL Limited Vaccine Adjuvants Revenue and Gross Margin (2019-2024)
3.11.4 CSL Limited Related Developments
3.12 Avanti Polar Lipids
3.12.1 Avanti Polar Lipids Information
3.12.2 Avanti Polar Lipids Overview
3.12.3 Avanti Polar Lipids Vaccine Adjuvants Revenue and Gross Margin (2019-2024)
3.12.4 Avanti Polar Lipids Related Developments
4 Global Vaccine Adjuvants Market Insights
4.1 Global Vaccine Adjuvants Market Revenue 2019-2024
4.2 Global Vaccine Adjuvants Revenue by Region
4.3 Americas
4.4 Europe
4.5 Asia-Pacific
4.6 Middle East & Africa
5 Market Size by Type
5.1 Global Vaccine Adjuvants Revenue by Type
5.2 Global Vaccine Adjuvants Market Size Growth by Type 2019-2024
6 Market Size by Application
6.1 Global Vaccine Adjuvants Revenue by Application
6.2 Global Vaccine Adjuvants Market Size Growth by Application 2019-2024
7 Americas
7.1 Americas Vaccine Adjuvants Market Size by Type
7.1.1 Americas Vaccine Adjuvants Revenue by Type (2019-2024)
7.1.2 Americas Vaccine Adjuvants Revenue Share by Type (2019-2024)
7.2 Americas Vaccine Adjuvants Market Size by Application
7.2.1 Americas Vaccine Adjuvants Revenue by Application (2019-2024)
7.2.2 Americas Vaccine Adjuvants Revenue Share by Application (2019-2024)
7.3 Americas Vaccine Adjuvants Market Size by Country
7.3.1 Americas Vaccine Adjuvants Revenue by Country (2019-2024)
7.3.2 U.S.
7.3.3 Canada
7.3.4 Mexico
7.3.5 Brazil
7.3.6 Argentina
8 Europe
8.1 Europe Vaccine Adjuvants Market Size by Type
8.1.1 Europe Vaccine Adjuvants Revenue by Type (2019-2024)
8.1.2 Europe Vaccine Adjuvants Revenue Share by Type (2019-2024)
8.2 Europe Vaccine Adjuvants Market Size by Application
8.2.1 Europe Vaccine Adjuvants Revenue by Application (2019-2024)
8.2.2 Europe Vaccine Adjuvants Revenue Share by Application (2019-2024)
8.3 Europe Vaccine Adjuvants Market Size by Country
8.3.1 Europe Vaccine Adjuvants Revenue by Country (2019-2024)
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
9 Asia Pacific
9.1 Asia Pacific Vaccine Adjuvants Market Size by Type
9.1.1 Asia Pacific Vaccine Adjuvants Revenue by Type (2019-2024)
9.1.2 Asia Pacific Vaccine Adjuvants Revenue Share by Type (2019-2024)
9.2 Asia Pacific Vaccine Adjuvants Market Size by Application
9.2.1 Asia Pacific Vaccine Adjuvants Revenue by Application (2019-2024)
9.2.2 Asia Pacific Vaccine Adjuvants Revenue Share by Application (2019-2024)
9.3 Asia Pacific Vaccine Adjuvants Market Size by Region
9.3.1 Asia Pacific Vaccine Adjuvants Revenue by Region (2019-2024)
9.3.2 China
9.3.3 Japan
9.3.4 South Korea
9.3.5 India
9.3.6 Southeast Asia
9.3.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Vaccine Adjuvants Market Size by Type
10.1.1 Middle East and Africa Vaccine Adjuvants Revenue by Type (2019-2024)
10.1.2 Middle East and Africa Vaccine Adjuvants Revenue Share by Type (2019-2024)
10.2 Middle East and Africa Vaccine Adjuvants Market Size by Application
10.2.1 Middle East and Africa Vaccine Adjuvants Revenue by Application (2019-2024)
10.2.2 Middle East and Africa Vaccine Adjuvants Revenue Share by Application (2019-2024)
10.3 Middle East and Africa Vaccine Adjuvants Market Size by Country
10.3.1 Middle East and Africa Vaccine Adjuvants Revenue by Country (2019-2024)
10.3.2 Turkey
10.3.3 Saudi Arabia
10.3.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Vaccine Adjuvants Industry Trends
11.2 Vaccine Adjuvants Market Drivers
11.3 Vaccine Adjuvants Market Challenges
11.4 Vaccine Adjuvants Market Restraints
12 Vaccine Adjuvants Forecasted Market Size by Type
12.1 Global Vaccine Adjuvants Forecasted Revenue by Type
12.2 Global Vaccine Adjuvants Forecasted Market Size Growth by Type 2024-2030
13 Vaccine Adjuvants Forecasted Market Size by Application
13.1 Global Vaccine Adjuvants Forecasted Revenue by Application
13.2 Global Vaccine Adjuvants Forecasted Market Size Growth by Application 2024-2030
14 Global Vaccine Adjuvants Market Forecasts
14.1 Global Vaccine Adjuvants Market Revenue Forecasts 2024-2030
14.2 Global Vaccine Adjuvants Forecasts Revenue by Region
14.3 Americas
14.3.1 Americas Vaccine Adjuvants Forecasts Revenue by Country (2019-2024)
14.4 Europe
14.4.1 Europe Vaccine Adjuvants Forecasts Revenue by Country (2019-2024)
14.5 Asia-Pacific
14.5.1 Asia Pacific Vaccine Adjuvants Forecasts Revenue by Country (2019-2024)
14.6 Middle East & Africa
14.6.1 Middle East and Africa Vaccine Adjuvants Forecasts Revenue by Country (2019-2024)
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer